BFM 89.9
The Business Station
Recommended
26 mins
23 mins
26 mins
Merck & Co’s oral antiviral for COVID-19 is being called a “game-changer”, as it would be the first pill available to treat early infection. In another first, the company has agreed to a licensing deal that will allow the drug to be made and sold cheaply in 105 low-income countries. We ask Sangeeta Shashikant, Programme Director on Development & Intellectual Property, Third World Network, whether this move will be enough to make the drug accessible, especially when rich countries look set to hoard supplies amid already existing vaccine inequity.
Listen to Part 1 here, where we explore how molnupiravir works and how it could change the way COVID-19 is managed.
Image credit: The Intercept
Presenter:
Producer: Lim Sue Ann and Tee Shiao Eek
The Bigger Picture
Health & Living
COVID-19
Merck
molnupiravir
antiviral
remdesivir
equity
generic
intellectual property
medicines patent pool
IP waiver
Share:
Recent episodes
0
Latest stories
Podcasts · Jan 21 · 12:00PM
New Era, New Stripes: Can Harimau Malaya Turn The Tide?
28 mins
Podcasts · Jan 21 · 10:00AM
Do Looks Matter in the Workplace?
1 hr 24 mins
Podcasts · Jan 21 · 9:00AM
Top 5 at 5: Inside Trump's Inauguration
40 mins
Can We Afford The First Pill for COVID-19?
22 mins
·
16:35, 2 Nov 2021
Merck & Co’s oral antiviral for COVID-19 is being called a “game-changer”, as it would be the first pill available to treat early infection. In another first, the company has agreed to a licensing deal that will allow the drug to be made and sold cheaply in 105 low-income countries. We ask Sangeeta Shashikant, Programme Director on Development & Intellectual Property, Third World Network, whether this move will be enough to make the drug accessible, especially when rich countries look set to hoard supplies amid already existing vaccine inequity.
Listen to Part 1 here, where we explore how molnupiravir works and how it could change the way COVID-19 is managed.
Image credit: The Intercept
Presenter:
Producer: Lim Sue Ann and Tee Shiao Eek
The Bigger Picture
Health & Living
COVID-19
Merck
molnupiravir
antiviral
remdesivir
equity
generic
intellectual property
medicines patent pool
IP waiver
Share:
Recommended
May 10
·
23 minsWhat It Takes To Get Your Bread Right
May 9
·
26 minsConfronting Bullying In The Workplace
Download app
60,000 other podcasts in your hand
Recent episodes
0
Latest Stories
Podcasts · Jan 21 · 28 mins
New Era, New Stripes: Can Harimau Malaya Turn The Tide?
Podcasts · Jan 21 · 1 hr 24 mins
Do Looks Matter in the Workplace?
Podcasts · Jan 21 · 40 mins
Top 5 at 5: Inside Trump's Inauguration